Jessica Hopfield, Ph.D. is a former partner of McKinsey & Company in their Global Pharmaceutical practice. While at McKinsey from 1995-2009, she served clients across pharmaceutical, biotech, medical device and consumer industries with a focus on strategy, R&D management and marketing.
Dr. Hopfield serves as an independent director of rEVO Biologics, a biotechnology company focused on the development and commercialization of innovative and cost effective therapeutics for rare diseases. She also serves on the Board of Directors of Insulet Corporation.
She founded J Hopfield Consulting in 2010 to provide strategic guidance and executive coaching to start-up technology firms seeking to commercialize intellectual property. She previously held management positions at Merck Sharp and Dohme in Clinical Development, Outcomes Research, and Marketing.
Dr. Hopfield earned an MBA from Harvard Graduate School of Business Administration as a Baker Scholar, a PhD in neuroscience/biochemistry from the Rockefeller University, and a BS from Yale College.
Page last updated: March 23, 2017